News
POSTED 12 Feb 2018
MIMICS-2 at 1 year: 3D stent meets safety & effectiveness goals
The TCTMD reports on Timothy Sullivan's presentation at the International Symposium on Endovascular Therapy.
Read the full article by the TCTMD.
©Veryan Medical 2022
BioMimics 3D Vascular Stent System has FDA and CE Mark approval.
BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited.
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies.
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
PAM 14 Version 3.0
